NASDAQ : PLUR
Pluri Inc. — Key statistics
Healthcare · Biotechnology · Israel
Last price 1.2 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 14.81M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 14.81M |
| Enterprise Value | 41.92M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 12.34M |
| Shares Outstanding | 12.34M |
| Shares Change (YoY) | +53.76% |
| Shares Change (QoQ) | +6.22% |
| Owned by Insiders (%) | 36.84% |
| Owned by Institutions (%) | 11.02% |
| Float | 5.75M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.82 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 41.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.27 |
| Quick Ratio | 0.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.76 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -49.04% |
| Return on Invested Capital (ROIC) | -61.53% |
| Return on Capital Employed (ROCE) | 318.05% |
| Weighted Average Cost of Capital (WACC) | 3.89% |
| Revenue Per Employee | $8,991 |
| Profits Per Employee | -$210,805 |
| Employee Count | 113 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -25,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -69.23% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 2.37 |
| Relative Strength Index (RSI) | 58.06 |
| Average Volume (20 Days) | 64,184 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 21,034 |
| Short Previous Month | 19,310 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.37% |
| Short Ratio (days to cover) | 1.26 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.02M |
| Gross Profit | 453,000 |
| Operating Income | -24.94M |
| Pretax Income | -25.39M |
| Net Income | -23.82M |
| EBITDA | -24.43M |
| EBIT | -24.94M |
| Loss Per Share | -$2.44 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 7.80M |
| Total Debt | 34.91M |
| Net Cash | -27.11M |
| Net Cash Per Share | -$2.20 |
| Equity (Book Value) | -17.43M |
| Book Value Per Share | -2.13 |
| Working Capital | -23.99M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -19.59M |
| Capital Expenditures | -633,000 |
| Depreciation & Amortization | 511,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -20.22M |
| FCF Per Share | -$1.64 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.59% |
| Operating Margin | -2,454.53% |
| Pretax Margin | -2,499.41% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -53.76% |
| Shareholder Yield | -53.76% |
| Earnings Yield | -203.73% |
| FCF Yield | -134.26% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 1, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -30.22 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |